Nuvation Operating Income vs Total Operating Expenses Analysis

NUVB Stock  USD 2.80  0.15  5.08%   
Nuvation Bio financial indicator trend analysis is infinitely more than just investigating Nuvation Bio recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Nuvation Bio is a good investment. Please check the relationship between Nuvation Bio Operating Income and its Total Operating Expenses accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nuvation Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For information on how to trade Nuvation Stock refer to our How to Trade Nuvation Stock guide.

Operating Income vs Total Operating Expenses

Operating Income vs Total Operating Expenses Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Nuvation Bio Operating Income account and Total Operating Expenses. At this time, the significance of the direction appears to have pay attention.
The correlation between Nuvation Bio's Operating Income and Total Operating Expenses is -0.99. Overlapping area represents the amount of variation of Operating Income that can explain the historical movement of Total Operating Expenses in the same time period over historical financial statements of Nuvation Bio, assuming nothing else is changed. The correlation between historical values of Nuvation Bio's Operating Income and Total Operating Expenses is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Operating Income of Nuvation Bio are associated (or correlated) with its Total Operating Expenses. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Operating Expenses has no effect on the direction of Operating Income i.e., Nuvation Bio's Operating Income and Total Operating Expenses go up and down completely randomly.

Correlation Coefficient

-0.99
Relationship DirectionNegative 
Relationship StrengthSignificant

Operating Income

Operating Income is the amount of profit realized from Nuvation Bio operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Nuvation Bio is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.
Most indicators from Nuvation Bio's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Nuvation Bio current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nuvation Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For information on how to trade Nuvation Stock refer to our How to Trade Nuvation Stock guide.As of September 22, 2024, Selling General Administrative is expected to decline to about 22.1 M. In addition to that, Enterprise Value Over EBITDA is expected to decline to -3.08
 2021 2022 2023 2024 (projected)
Interest Income3.0M7.4M24.6M25.8M
Net Interest Income3.0M7.4M24.6M25.8M

Nuvation Bio fundamental ratios Correlations

0.92-0.880.921.00.980.990.980.93-0.910.930.940.40.580.980.95-0.040.980.84-0.590.960.980.740.66-0.430.95
0.92-0.940.760.930.960.950.960.96-0.80.860.960.380.270.960.960.240.970.83-0.460.910.950.680.55-0.660.97
-0.88-0.94-0.74-0.88-0.88-0.89-0.89-0.920.66-0.73-0.94-0.4-0.22-0.88-0.92-0.09-0.9-0.690.19-0.77-0.93-0.44-0.280.75-0.93
0.920.76-0.740.90.850.880.850.75-0.840.860.750.240.690.850.79-0.240.840.73-0.630.880.840.750.68-0.370.77
1.00.93-0.880.90.990.990.990.95-0.920.940.950.460.550.990.940.010.990.88-0.570.960.990.720.65-0.410.96
0.980.96-0.880.850.990.991.00.97-0.920.950.960.460.491.00.950.091.00.9-0.580.970.990.740.66-0.460.97
0.990.95-0.890.880.990.990.990.95-0.920.940.950.410.550.990.95-0.010.990.87-0.580.970.990.740.66-0.470.96
0.980.96-0.890.850.991.00.990.97-0.920.950.970.460.491.00.950.091.00.9-0.580.970.990.740.65-0.460.98
0.930.96-0.920.750.950.970.950.97-0.830.861.00.570.30.970.950.220.980.86-0.390.880.980.570.48-0.490.99
-0.91-0.80.66-0.84-0.92-0.92-0.92-0.92-0.83-0.99-0.81-0.51-0.69-0.92-0.780.04-0.9-0.950.75-0.95-0.87-0.82-0.80.15-0.82
0.930.86-0.730.860.940.950.940.950.86-0.990.840.490.640.950.81-0.020.930.96-0.710.970.90.830.77-0.30.86
0.940.96-0.940.750.950.960.950.971.0-0.810.840.510.290.960.970.220.980.82-0.390.880.980.570.48-0.521.0
0.40.38-0.40.240.460.460.410.460.57-0.510.490.510.130.460.30.160.440.660.060.310.47-0.02-0.020.10.45
0.580.27-0.220.690.550.490.550.490.3-0.690.640.290.130.490.34-0.70.450.48-0.660.590.470.620.660.170.31
0.980.96-0.880.850.991.00.991.00.97-0.920.950.960.460.490.950.091.00.9-0.590.970.990.750.66-0.460.97
0.950.96-0.920.790.940.950.950.950.95-0.780.810.970.30.340.950.150.970.74-0.470.90.970.650.55-0.570.98
-0.040.24-0.09-0.240.010.09-0.010.090.220.04-0.020.220.16-0.70.090.150.110.170.010.040.040.020.0-0.140.22
0.980.97-0.90.840.991.00.991.00.98-0.90.930.980.440.451.00.970.110.87-0.550.960.990.720.63-0.480.99
0.840.83-0.690.730.880.90.870.90.86-0.950.960.820.660.480.90.740.170.87-0.610.890.840.730.67-0.240.82
-0.59-0.460.19-0.63-0.57-0.58-0.58-0.58-0.390.75-0.71-0.390.06-0.66-0.59-0.470.01-0.55-0.61-0.76-0.47-0.95-0.99-0.09-0.45
0.960.91-0.770.880.960.970.970.970.88-0.950.970.880.310.590.970.90.040.960.89-0.760.930.890.82-0.390.9
0.980.95-0.930.840.990.990.990.990.98-0.870.90.980.470.470.990.970.040.990.84-0.470.930.650.55-0.50.98
0.740.68-0.440.750.720.740.740.740.57-0.820.830.57-0.020.620.750.650.020.720.73-0.950.890.650.97-0.220.63
0.660.55-0.280.680.650.660.660.650.48-0.80.770.48-0.020.660.660.550.00.630.67-0.990.820.550.970.010.53
-0.43-0.660.75-0.37-0.41-0.46-0.47-0.46-0.490.15-0.3-0.520.10.17-0.46-0.57-0.14-0.48-0.24-0.09-0.39-0.5-0.220.01-0.53
0.950.97-0.930.770.960.970.960.980.99-0.820.861.00.450.310.970.980.220.990.82-0.450.90.980.630.53-0.53
Click cells to compare fundamentals

Nuvation Bio Account Relationship Matchups

Nuvation Bio fundamental ratios Accounts

201920202021202220232024 (projected)
Total Current Liabilities3.2M6.6M16.9M13.2M14.0M10.0M
Net Tangible Assets(24.1M)(52.4M)746.0M655.1M753.3M791.0M
Retained Earnings(34.3M)(76.0M)(162.8M)(267.0M)(342.8M)(325.7M)
Accounts Payable2.0M2.2M3.9M2.1M2.2M2.3M
Total Current Assets119.9M220.7M772.1M667.3M616.4M439.4M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Information and Resources on Investing in Nuvation Stock

When determining whether Nuvation Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Nuvation Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nuvation Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nuvation Bio Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Nuvation Bio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real.
For information on how to trade Nuvation Stock refer to our How to Trade Nuvation Stock guide.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nuvation Bio. If investors know Nuvation will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nuvation Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.22)
Revenue Per Share
0.006
Return On Assets
(0.54)
Return On Equity
(0.88)
The market value of Nuvation Bio is measured differently than its book value, which is the value of Nuvation that is recorded on the company's balance sheet. Investors also form their own opinion of Nuvation Bio's value that differs from its market value or its book value, called intrinsic value, which is Nuvation Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nuvation Bio's market value can be influenced by many factors that don't directly affect Nuvation Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nuvation Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Nuvation Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nuvation Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.